A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...
People with rheumatoid arthritis usually depend on drugs to control pain in their joints. But this summer, the Food and Drug Administration approved a different sort of treatment. It's a device that ...
MedPage Today on MSN
Not all drugs approved for rheumatoid arthritis are equal for pain relief
The same analysis performed on data from the similarly designed SELECT-PsA 1 trial in psoriatic arthritis showed similar ...
Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer ...
Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback